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Background: Transcriptional adaptations are thought to influence skeletal muscle morphology in heart failure (HF) patients. Suppression of 
P13k/Akt signaling involves activation of transcription factors (e.g. FoxO) that lead to muscular atrophy, while activation of peroxisome-proliferator-
activated receptor-aco-activator-1alpha (PGC-1_) and insulin-like growth factor binding protein-5 (IGFBP-5) are associated with improved muscle 
function.
Methods: Peak oxygen consumption (VO2) and ventilatory efficiency slope were assessed by cardiopulmonary exercise testing in systolic HF 
patients and age-matched controls. Leg strength was evaluated by the one repetition maximum and sub-maximal power. Vastus lateralis biopsies 
were completed and skeletal muscle assessed for gene expression using polymerase chain reaction. Body composition was completed by dual x-ray 
absorptiometry.
Results: 51 male adults (23 HF age 67.3 ± 9.5 and 28 controls age 66.9 ± 10.5) were assessed. Aerobic capacity and muscular strength/power 
were decreased in HF. While gene expression of PGC-1_, IGFBP-5, and body composition were similar in HF and controls (Table; A), these genes 
positively-correlated with aerobic performance only in HF (Table; B).
Conclusion: Aerobic and strength indices are lower in HF patients. Differences in physical function positively correlate with PGC-1_ and IGFBP-5 
expression, which may underlie critical distinctions in peripheral muscular efficiency in oxygen utilization.
 
